|Articles|July 1, 2000

July 2000
Volume 6
Issue 7

Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity

Author(s)Martha L. Hutchinson, PhD, MD, Barry M. Berger, MD, Fredric L. Farber, BS

Download PDF: Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity

Articles in this issue

about 26 years ago

Article

Improving the Sensitivity of Cervical Cytology: What Are the Issues?

about 26 years ago

Article

Why Are Drug Prices Lower in Canada?

about 26 years ago

Article

Comparing the Medical Expenses of Children with Medicaid and Commercial Insurance in an HMO

about 26 years ago

Article

High-Risk Population Health Management -- Achieving Improved Patient Outcomes and Near-Term Financial Results

about 26 years ago

Article

Design and Implementation of an Inpatient Disease Management Program

about 26 years ago

Article

Managing Drug Costs: The Perception of Managed Care Pharmacy Directors

about 26 years ago

Article

Interactive Voice Response Systems in the Diagnosis and Management of Chronic Disease

about 26 years ago

Article

Mandated Managed Care for Blind and Disables Medicaid Beneficiaries in a County-Organized Health System: Implementation Challenges and Access Issues

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access